Abstract
AbstractRadioembolization has gained wide acceptance as a safe and efficient treatment for unresectable liver-dominant metastatic colorectal cancer. In this comprehensive article, we focus on clinical outcomes and dosimetry models in the era of personalized medicine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have